Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit, with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC patients who were surgically ablated need no radioiodine remnant ablation (RRA). This study aims to evaluate the long...

Descripción completa

Detalles Bibliográficos
Autores principales: Bal, Chandrasekhar, Ballal, Sanjana, Soundararajan, Ramya, Chopra, Saurav, Garg, Aayushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529341/
https://www.ncbi.nlm.nih.gov/pubmed/25755077
http://dx.doi.org/10.1002/cam4.443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529341/
https://www.ncbi.nlm.nih.gov/pubmed/25755077
http://dx.doi.org/10.1002/cam4.443

Ejemplares similares